How Women and Six Sigma Have Contributed to Pfizer's Robustness Program

Sarah Duggan, Ursula Sheridan, Rebecca Deasy, Deirdre Murphy, Lorna Moynihan

Research output: Contribution to journalArticlepeer-review


Pfizer Ireland Ringaskiddy is the new product launch site for the global Pfizer network, but as well as new products, the site manufactures an array of both on- and off-patent active pharmaceutical ingredients (APIs). Chemistry is at the forefront of the site, and the Chemistry Centre of Excellence (COE) within Ringaskiddy hosts a wealth of experience and knowledge, with a strong female representation in both process and technical chemist roles. There is a continual focus on process robustness across the site. Green Belt (GB) projects focus on resolving and eliminating process deviations using Six Sigma tools by a cross-functional team. This article will focus on three GB projects on two different APIs manufactured at Ringaskiddy which were led by female process chemists.

Original languageEnglish
Pages (from-to)616-620
Number of pages5
JournalOrganic Process Research and Development
Issue number3
Publication statusPublished - 19 Mar 2021
Externally publishedYes


  • API manufacturing
  • deviations
  • Palbociclib
  • robustness
  • Six Sigma
  • Tofacitinib Citrate


Dive into the research topics of 'How Women and Six Sigma Have Contributed to Pfizer's Robustness Program'. Together they form a unique fingerprint.

Cite this